Maged Shenouda
Chief Financial Officer at Relmada Therapeutics · 4 reported transactions in 1 company · latest trade Sep 10, 2026
Their record
Across their whole record, 1 purchase can be measured; 1 did better than the S&P 500 over the next 6 months.
Typical move +199.6%, S&P 500 +6.1% over the same days.
Their trades
Bought | Sep 10, 2026 | Sep 10, 2026 close $4.07 → Oct 23, 2026 close $3.27. S&P 500 +0.3% over the same days. | ||
Bought | Sep 9, 2026 | Sep 9, 2026 close $4.09 → Oct 23, 2026 close $3.27. S&P 500 −0.3% over the same days. | ||
Bought | Dec 15, 2025 | Dec 15, 2025 close $4.36 → Oct 23, 2026 close $3.27. S&P 500 +11.6% over the same days. | ||
Bought | Nov 5, 2025 | Nov 5, 2025 close $2.51 → Oct 23, 2026 close $3.27. S&P 500 +12.2% over the same days. |
BoughtRelmada Therapeutics
$339.1K
Sep 10, 2026 close $4.07 → Oct 23, 2026 close $3.27. S&P 500 +0.3% over the same days.
BoughtRelmada Therapeutics
$504.8K
Sep 9, 2026 close $4.09 → Oct 23, 2026 close $3.27. S&P 500 −0.3% over the same days.
BoughtRelmada Therapeutics
$48.1K
Dec 15, 2025 close $4.36 → Oct 23, 2026 close $3.27. S&P 500 +11.6% over the same days.
BoughtRelmada Therapeutics
$1.1M
Nov 5, 2025 close $2.51 → Oct 23, 2026 close $3.27. S&P 500 +12.2% over the same days.